- Home
- ROIV vs PPL Comparison
ROIV vs PPL Comparison
Compare ROIV & PPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ROIV | PPL |
|---|---|---|
| Founded | 2014 | 1920 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.2B | 26.7B |
| IPO Year | 2021 | 2007 |
Fundamental Metrics
Financial Performance| Metric | ROIV | PPL |
|---|---|---|
| Price | $35.01 | $36.17 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 13 |
| Target Price | $28.94 | ★ $41.08 |
| AVG Volume (30 Days) | 5.0M | ★ 7.0M |
| Earning Date | 05-28-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 2.95% |
| EPS Growth | N/A | ★ 32.50 |
| EPS | N/A | ★ 1.59 |
| Revenue | $8,260,000.00 | ★ $9,042,000,000.00 |
| Revenue This Year | N/A | $7.23 |
| Revenue Next Year | $744.61 | $5.85 |
| P/E Ratio | ★ N/A | $22.79 |
| Revenue Growth | N/A | ★ 6.85 |
| 52 Week Low | $10.90 | $33.17 |
| 52 Week High | $37.00 | $40.11 |
Technical Indicators
Market Signals| Indicator | ROIV | PPL |
|---|---|---|
| Relative Strength Index (RSI) | 57.78 | 53.85 |
| Support Level | $33.56 | $34.80 |
| Resistance Level | $37.00 | $36.97 |
| Average True Range (ATR) | 1.11 | 0.60 |
| MACD | -0.24 | 0.03 |
| Stochastic Oscillator | 41.02 | 67.35 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About PPL PPL Corporation
PPL is a holding company of regulated utilities in Pennsylvania, Kentucky, and Rhode Island. The Pennsylvania regulated delivery and transmission segment distributes electricity to customers in central and eastern Pennsylvania. In Kentucky, LG&E and KU are involved in regulated electricity generation, transmission, and distribution. LG&E also provides regulated natural gas distribution. Rhode Island Energy operates electric and gas utilities in the state.